» Articles » PMID: 15971545

Assessing Parallelism Prior to Determining Relative Potency

Overview
Specialty Pharmacology
Date 2005 Jun 24
PMID 15971545
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

In the course of preparing a revision to Chapter (111) of the U.S. Pharmacopeia, the revision committee came to a unanimous agreement that the method for assessing parallelism that is currently presented in (111) and in the European Pharmacopeia's Chapter 5.3 is flawed and should be replaced. The symptoms are that perfectly acceptable assay results may fail due to good precision and that obviously faulty assay results may pass due to poor precision. The flaw is that the wrong statistical technique has been used. We propose an alternative approach based on the equivalence testing paradigm that does not have these shortcomings. Equivalence testing requires the establishment of equivalence limits. Specific approaches for establishing equivalence limits are discussed.

Citing Articles

Establishing a new human pneumococcal standard reference serum, MPRSS-01.

Antonello J, Murphy R, Abeygunawardana C, Malinverni J, Gowrisankar R, Green T mSphere. 2025; 10(1):e0040424.

PMID: 39772874 PMC: 11774022. DOI: 10.1128/msphere.00404-24.


Development of an In Vitro Test Method to Replace an Animal-Based Potency Test for Pertactin Antigen in Multivalent Vaccines.

Szeto J, Beharry A, Chen T, Zholumbetov E, Daigneault E, Ming M Vaccines (Basel). 2023; 11(2).

PMID: 36851153 PMC: 9965796. DOI: 10.3390/vaccines11020275.


A high-performance, non-radioactive potency assay for measuring cytotoxicity: A full substitute of the chromium-release assay targeting the regulatory-compliance objective.

Rossignol A, Bonnaudet V, Clemenceau B, Vie H, Bretaudeau L MAbs. 2017; 9(3):521-535.

PMID: 28281922 PMC: 5384798. DOI: 10.1080/19420862.2017.1286435.


Interlaboratory comparison of results of an anthrax lethal toxin neutralization assay for assessment of functional antibodies in multiple species.

Omland K, Brys A, Lansky D, Clement K, Lynn F Clin Vaccine Immunol. 2008; 15(6):946-53.

PMID: 18417668 PMC: 2446612. DOI: 10.1128/CVI.00003-08.


A TaqMan reverse transcription polymerase chain reaction (RT-PCR) in vitro potency assay for plasmid-based vaccine products.

Mahajan R, Feher B, Jones B, Jones D, Marjerison L, Sam M Mol Biotechnol. 2008; 40(1):47-57.

PMID: 18365771 DOI: 10.1007/s12033-008-9058-3.